IIT Kanpur, Conlis Global sign MoU for new indigenously developed bone regeneration tech
IIT Kanpur Signs MoU with Conlis Global for Innovative Bone Healing Technology
Kanpur, Feb 22 (IANS) The Indian Institute of Technology (IIT) Kanpur has partnered with Canada-based biotechnology company Conlis Global to license an innovative technology for bone healing and regeneration. The technology, Hydroxyapatite based Porous Composite Scaffolds, aims to address the drawbacks of existing bone healing remedies and provide a promising approach for reconstructing and repairing bone defects.
The novel technology is biodegradable and has osteoinductive and osteopromotive properties for bone regeneration. It facilitates bone regeneration by acting as a carrier for bone-active biomolecules, delivering them directly to the site of an implant. Additionally, the functionalized scaffolds can be used as fillers in large size bone defects while maintaining connectivity and structural integrity.
Prof. Ashok Kumar, Department of Biological Sciences & Bioengineering at IIT Kanpur, stated, “The material is a promising approach for reconstructing and repairing bone defects while addressing the drawbacks and complications associated with technologies that are available in the market at present.”
The primary objective of the invention is to overcome the drawbacks of existing remedies, such as infection and immune-related complications. The technology also provides an approach for the delivery of bone-active molecules, antibiotics, or other drugs for combating bone pathologies, reconstructing irregular bone defects, and for dental applications.
Dr. Sumrita Bhat, CEO of Conlis Global, expressed excitement about the partnership, stating, “We are thrilled to partner with IIT Kanpur to bring this innovative solution to the market. It represents a significant step forward in treating bone and joint disorders, and we look forward to taking this to market to benefit patients worldwide.”
The MoU signed between IIT Kanpur and Conlis Global marks a significant development in the field of bone healing and regeneration, with potential benefits for patients worldwide.
